Dudediligence.

Sagimet Biosciences Inc

SGMTNASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$3,893,742

4 notices · 427,725 sh

Oct 2025 to Oct 2026

Reported ·

$395,279

5 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

1 of 5 reported sales carry the 10b5-1 box.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-08-14: GEORGE KEMBLE, Form 1442026-08-11: GEORGE KEMBLE, Form 1442026-07-20: GEORGE KEMBLE, Form 1442025-11-20: GEORGE KEMBLE, Form 1442025-11-20: Kemble George, sold2026-02-10: Rozek Elizabeth, sold2026-02-10: Martins Eduardo Bruno, sold2026-02-10: Chauche Thierry, sold2026-02-10: Happel David, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-08-14GEORGE KEMBLE, Director$3,257,159
350,987 shplan 2025-08-21Form 4s on file end Jun 23144 ↗
2026-08-11GEORGE KEMBLE, Director$193,371
20,206 shplan 2025-08-21Form 4s on file end Jun 23144 ↗
2026-07-20GEORGE KEMBLE, Director, Officer$147,360
18,844 shplan 2025-08-21Form 4s on file end Jun 23144 ↗
2025-11-20GEORGE KEMBLE, Director, Officer$295,851
37,688 shplan 2025-08-21144 ↗
Form 4, 2025-11-21: sold 37,688 at $7.69 Form 4 ↗